Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	3.34	3.87	6.96	20.48
Cash & Short-Term Investments	2.19	3.34	3.87	6.96	20.48
Cash Growth	-34.55%	-13.55%	-44.44%	-66.04%	9.57%
Receivables	-	0.02	0.15	0.6	0.32
Prepaid Expenses	-	0.17	0.22	0.27	1.12
Other Current Assets	-	0.01	0	0	0.02
Total Current Assets	-	3.54	4.23	7.83	21.94
Property, Plant & Equipment	-	0.04	0.35	0.4	0.54
Long-Term Investments	-	7.09	-	-	-
Other Long-Term Assets	-	0.01	0.05	0.05	0.06
Total Assets	-	10.68	4.64	8.28	22.54
Accounts Payable	-	0.25	0.98	1.28	1.79
Accrued Expenses	-	0.54	1.4	1.72	2.06
Current Portion of Leases	-	0.01	0.27	0.29	0.29
Current Unearned Revenue	-	-	0.23	-	-
Total Current Liabilities	-	0.8	2.89	3.28	4.13
Long-Term Leases	-	0.03	0.07	0.09	0.19
Long-Term Unearned Revenue	-	-	0.09	-	-
Pension & Post-Retirement Benefits	-	0.16	0.44	-	1.28
Total Liabilities	-	1	3.5	3.37	5.61
Common Stock	-	1.84	1.84	1.15	49.27
Additional Paid-In Capital	-	266.38	266.19	269.51	283.98
Retained Earnings	-	-353.36	-360.42	-349.86	-329.06
Treasury Stock	-	-0.87	-0.91	-6.28	-11.7
Comprehensive Income & Other	-	95.68	94.44	90.39	24.44
Shareholders' Equity	5.96	9.68	1.15	4.91	16.93
Total Liabilities & Equity	-	10.68	4.64	8.28	22.54
Total Debt	0.04	0.04	0.34	0.37	0.48
Net Cash (Debt)	2.15	3.3	3.52	6.58	20
Net Cash Growth	-34.82%	-6.29%	-46.52%	-67.08%	10.34%
Net Cash Per Share	0.02	0.03	0.05	0.15	0.59
Filing Date Shares Outstanding	144.59	98.34	128.26	80.88	37.9
Total Common Shares Outstanding	116.57	98.34	125.2	77.13	37.9
Working Capital	-	2.74	1.34	4.55	17.81
Book Value Per Share	0.05	0.10	0.01	0.06	0.45
Tangible Book Value	5.96	9.68	1.15	4.91	16.93
Tangible Book Value Per Share	0.05	0.10	0.01	0.06	0.45
Machinery	-	0.08	1.73	1.72	1.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.